<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Viral Hepatitis</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Viral Hepatitis.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/viral-hepatitis.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta-Analysis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-jvh-70222-ec6cd0c2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-jvh-70222-ec6cd0c2/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The abstract characterizes HBV, HCV, HDV, MASLD, and alcohol use as preventable causes or contributors considered in relation to liver cancer. It states that the findings support integrating hepatocellular carcinoma surveillance into management of viral hepatitis.</description>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>Surveillance</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Hepatitis B Immunization Among Healthcare Students: A Narrative Review of Occupational Risk, Seroprotection, and Immunization Management</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14090732-18f977c3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14090732-18f977c3/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The abstract identifies healthcare-student HBV exposure, incomplete vaccination documentation, heterogeneous schedules, and variable institutional protocols as occupational-health and prevention concerns. It describes pre-clinical serological assessment and structured immunization management as operational approaches discussed by the review.</description>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>CRISPR-based point-of-care diagnostics for viral hepatitis: from molecular design to clinical implementation</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fbioe-2026-1892898-b3b05b03/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fbioe-2026-1892898-b3b05b03/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>Faster pathogen identification could facilitate earlier therapeutic interventions and strengthen broader elimination campaigns. Decentralized testing formats offer potential to reduce specimen transit times and improve patient retention throughout diagnostic sequences.</description>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>Hepatitis A</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Serologic Immunity to Hepatitis A and B in US Adults and High-Risk Populations</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1001-jamainternmed-2026-3831-dca77f2e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1001-jamainternmed-2026-3831-dca77f2e/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>Widespread susceptibility across multiple demographic and clinical strata suggests current immunization coverage falls short of optimal population thresholds. These results emphasize the necessity for focused preventive campaigns directed toward underserved and medically vulnerable communities.</description>
    <category>Hepatitis A</category>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Africa’s Silent Humanitarian Crisis: Why Viral Hepatitis Must No Longer Be Ignored</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-rescon-vmag135-8768e99e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-rescon-vmag135-8768e99e/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article positions viral hepatitis as an urgent public health priority warranting immediate action through expanded testing, diagnosis, treatment, birth-dose vaccination, and integration with Universal Health Coverage initiatives.</description>
    <category>Viral Hepatitis</category>
    <category>Malaria</category>
    <category>Chronic hepatitis B</category>
    <category>Tuberculosis</category>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Seroprevalence of hepatitis D among hepatitis B-infected patients attending the viral hepatitis treatment unit in Alexandria, Egypt: a prospective cross-sectional observational study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13956-6-eb913973/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13956-6-eb913973/</guid>
    <pubDate>Fri, 14 Aug 2026 00:00:00 GMT</pubDate>
    <description>The observed exposure frequency underscores a notable co-infection burden within this regional hepatitis B population, indicating that routine diagnostic evaluation could enhance case identification in comparable healthcare environments.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis A</category>
    <category>Treatment</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Global burden and forecast of acute viral hepatitis B among women of childbearing age: a systematic analysis of the global burden of disease study 2021.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13302-w-894581b6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13302-w-894581b6/</guid>
    <pubDate>Sat, 16 May 2026 00:00:00 GMT</pubDate>
    <description>These epidemiological insights assist policymakers in designing region-targeted intervention frameworks and support broader international objectives for viral hepatitis management. The results emphasize the continued importance of sustaining immunization programs, enforcing sterile medical practices, and delivering effective maternal transmission safeguards.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Acute hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Sex-specific burdens of acute hepatitis B and C and their attributable risk factors in 204 countries and territories, 1990-2021.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-00942-6-900f1df6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-00942-6-900f1df6/</guid>
    <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
    <description>Ongoing demographic and geographic inequalities emphasize the importance of customized intervention approaches, such as enhanced immunization campaigns, expanded diagnostic testing, improved therapeutic access, and risk reduction measures to align with international elimination targets.</description>
    <category>Hepatitis C</category>
    <category>Acute hepatitis B</category>
    <category>Hepatitis B</category>
    <category>Acute hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Viral Hepatitis</category>
    <category>COVID-19</category>
    <category>Climate and environment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>[Trends and Epidemiological Characteristics of Acute Hepatitis B among Foreign Nationals in the Republic of Korea, 2014-2024].</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-56786-phwr-2025-18-44-1-5a38d3b8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-56786-phwr-2025-18-44-1-5a38d3b8/</guid>
    <pubDate>Mon, 20 Oct 2025 00:00:00 GMT</pubDate>
    <description>The rising influx of international residents highlights the necessity for targeted disease control initiatives within the host country. Identifying gaps in immunization documentation and addressing potential barriers to medical access can inform more effective community-based prevention programs.</description>
    <category>Acute hepatitis B</category>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Travel medicine</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Ceftriaxone-Resistant Gonorrhea — China, 2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7312a2-110d0a68/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7312a2-110d0a68/</guid>
    <pubDate>Thu, 28 Mar 2024 00:00:00 GMT</pubDate>
    <description>The substantial increase in ceftriaxone resistance threatens gonorrhea treatment effectiveness in China, where gonorrhea ranked as the fourth most common notifiable infectious disease in 2022 with 96,313 reported cases. Effective diagnosis, treatment, and partner management are essential to prevent transmission of resistant strains.</description>
    <category>Gonorrhea</category>
    <category>Syphilis</category>
    <category>Tuberculosis</category>
    <category>Viral Hepatitis</category>
    <category>Treatment</category>
    <category>Antimicrobial resistance</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1017-s0950268898001411-0f91556f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1017-s0950268898001411-0f91556f/</guid>
    <pubDate>Thu, 01 Oct 1998 00:00:00 GMT</pubDate>
    <description>The findings suggest hepatitis A vaccination without immunoglobulin may be a viable outbreak control measure in institutional settings. The study also indicates increasing susceptibility to hepatitis A virus in central Italy over recent decades.</description>
    <category>Hepatitis A</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Gastroenteritis</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
